Literature DB >> 18956281

Thrombocytopenia in critically ill patients.

Marcel Levi1, Ester C Löwenberg.   

Abstract

Critically ill patients often have a low platelet count. A proper identification of the underlying cause of this abnormality is required, because various underlying disorders may necessitate different diagnostic and therapeutic management strategies. Platelets are part of the first line of defense of the body against bleeding, hence, thrombocytopenia may increase the risk of hemorrhage. In case of systemic inflammatory syndromes, such as the response to sepsis, disseminated intravascular platelet activation may occur, which will contribute to microvascular failure and thereby play a role in the development of organ dysfunction. A low platelet count is a strong and independent predictor of an adverse outcome in critically ill patients, thereby facilitating a simple and practical risk assessment in these patients and potentially guiding the use of complex or expensive treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18956281     DOI: 10.1055/s-0028-1092871

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  27 in total

1.  Platelet aggregation in severe sepsis.

Authors:  Gábor Woth; Adrienn Varga; Subhamay Ghosh; Miklós Krupp; Tamás Kiss; Lajos Bogár; Diana Mühl
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

2.  Hantavirus infection: a neglected diagnosis in thrombocytopenia and fever?

Authors:  Barbara Denecke; Boris Bigalke; Michael Haap; Dietrich Overkamp; Hendrik Lehnert; Christian S Haas
Journal:  Mayo Clin Proc       Date:  2010-11       Impact factor: 7.616

Review 3.  [Adjuvant treatment of sepsis: what is known?].

Authors:  C J Wiedermann
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-10-22       Impact factor: 0.840

4.  Genetic polymorphisms in the endotoxin receptor may influence platelet count as part of the acute phase response in critically ill children.

Authors:  Rachel S Agbeko; John W Holloway; Meredith L Allen; Shu Ye; Katy J Fidler; John Pappachan; Allan Goldman; David Pontefract; John Deanfield; Nigel J Klein; Mark J Peters
Journal:  Intensive Care Med       Date:  2010-03-18       Impact factor: 17.440

Review 5.  Hemostatic abnormalities in critically ill patients.

Authors:  Marcel Levi; Suthesh Sivapalaratnam
Journal:  Intern Emerg Med       Date:  2014-12-24       Impact factor: 3.397

Review 6.  The coagulopathy of acute sepsis.

Authors:  Jeff Simmons; Jean-Francois Pittet
Journal:  Curr Opin Anaesthesiol       Date:  2015-04       Impact factor: 2.706

7.  Role of platelet TLR4 expression in pathogensis of septic thrombocytopenia.

Authors:  Yong-Qiang Wang; Bing Wang; Yong Liang; Shu-Hua Cao; Li Liu; Xin-Nv Xu
Journal:  World J Emerg Med       Date:  2011

Review 8.  Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.

Authors:  Marcel Levi; Tom van der Poll; Marcus Schultz
Journal:  Semin Immunopathol       Date:  2011-07-30       Impact factor: 9.623

9.  Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers.

Authors:  Sisse R Ostrowski; Ronan M G Berg; Nis A Windeløv; Martin A S Meyer; Ronni R Plovsing; Kirsten Møller; Pär I Johansson
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

Review 10.  Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.

Authors:  Martina Molgora; Domenico Supino; Alberto Mantovani; Cecilia Garlanda
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.